BioStem Technologies Strengthens Placental Allograft and Umbilical Tissue Patent Portfolio
Newly issued U.S. Patent and pending allowances in the U.S. and Mexico extend protection for the company’s sterile placental allograft, micronized wound care, and umbilical cord extract technologies PR Audio: POMPANO BEACH, Fla., October 1, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – BioStem Technologies, Inc. (Nasdaq: BSEM) (“BioStem” or the […]
BioStem Technologies Announces $3 Million Private Placement Priced At-The-Market Under Nasdaq Rules
POMPANO BEACH, Fla., September 30, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – BioStem Technologies Inc. (Nasdaq: BSEM) (“BioStem” or the “Company”), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced that it has entered into definitive agreements for the issuance […]
Aclarion Welcomes NYU Langone Health to CLARITY Trial Network, Now Enrolling at Eleven Sites
PR Audio: BROOMFIELD, Colo., September 29, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, today announced NYU […]
BioStem Technologies Secures Up to $40 Million in a Committed Equity Facility
PR Audio: PR Video Overview: POMPANO BEACH, Fla., September 18, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – BioStem Technologies, Inc. (Nasdaq: BSEM) (“BioStem” or the “Company”), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced it has entered into a […]
BioStem Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference
POMPANO BEACH, Fla., Sept. 03, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) –BioStem Technologies Inc. (Nasdaq: BSEM) (“BioStem” or the “Company”), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced that Company management will present at the H.C. Wainwright 28th Annual Global Investment […]
Auddia Announces Influence Healthcare’s First Specialty Hospital LOI, Marking a Major Milestone in the Company’s Healthcare Expansion
Secures 24,000-square-foot Texas specialty hospital with four operating rooms LOI establishes Influence Healthcare occupancy of the hospital no later than June 1, 2027 Each OR is expected to drive $5M to $10M in annual revenue in support of Influence Healthcare’s high margin business model PR Audio: BOULDER, CO. September 1, 2026 – PRISM MediaWire (Press […]
First Choice Healthcare Solutions, Inc. Information on Share Consolidation
Melbourne, Fl., July 23, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – First Choice Healthcare Solutions, Inc., (OTC: FCHS), (“First Choice” or the “Company”), announced today that as previously approved by the Board of Directors of the Company on September 15, 2024, all current issued and outstanding publicly traded common stock […]
Aclarion Announces Presentation of Two Abstracts Highlighting Nociscan’s Growing Role in Real-World Clinical Practice
PR Audio: BROOMFIELD, Colo., July 21, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, today announced the […]
BioStem Technologies Publicly Files Form 10 Registration Statement with the Securities and Exchange Commission
Advances progress towards planned Nasdaq uplisting PR Audio: POMPANO BEACH, Fla., July 10, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – BioStem Technologies Inc. (OTC: BSEM) (“BioStem” or the “Company”), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced the filing […]
BioStem Technologies to Present at the Planet MicroCap Las Vegas 2026 Conference
POMPANO BEACH, Fla., June 10, 2026 — BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced that Company management will present at the Planet MicroCap Las Vegas 2026 Conference. BioStem is scheduled to present on Wednesday, June 17, 2026, at […]